In addition, in AML cells it has been shown that inhibition of HDAC1 and HDAC2 causes upregulation of miR-182 which directly targets RAD51, resulting in decrease of RAD51 expression [22]. The gene discussed is HDAC1; the disease is acute myeloid leukemia.